<DOC>
	<DOCNO>NCT00005058</DOCNO>
	<brief_summary>RATIONALE : New image procedure , enhance ultrasound may improve ability determine extent breast cancer . PURPOSE : Diagnostic study enhance ultrasound woman locally advance primary breast cancer .</brief_summary>
	<brief_title>Enhanced Ultrasound Determining Extent Disease Women With Primary Breast Cancer</brief_title>
	<detailed_description>OBJECTIVES : I . Measure blood flow primary breast lesion correspond lymph node Power Doppler Ultrasound ( PDU ) compare information metastatic potential patient survival woman primary breast cancer . II . Correlate intratumor/-nodal blood flow pathological variable use standard histology special stain patient population . III . Correlate intratumor microvessel density total tumor blood flow presence axillary lymph node metastasis use diagnostic method patient . IV . Correlate tumor blood flow various marker angiogenesis use diagnostic method patient . V. Compare tumor blood flow measure PDU contrast enhancement patient . OUTLINE : This diagnostic study . Patients receive ultrasound contrast agent IV . An ultrasound probe Power Doppler facility sweep skin surface standard fashion contrast enhancement . Blood flow data acquire volume mass and/or lymph node use video recorder . The scanning time range 5 15 minute depend size exact location breast mass axillary lymph node . Within 1 week ultrasound , patient undergo surgery mass axillary lymph node remove . PROJECTED ACCRUAL : Approximately 200 patient accrue study within 1 year .</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Clinically suspect locally advanced breast cancer treatment indicate primary surgery ( wide local excision simple mastectomy ) axillary dissection ( clearance ) Inflammatory breast cancer eligible No recurrent disease Hormone receptor status : Not specify PATIENT CHARACTERISTICS : Age : 18 Sex : Female Menopausal status : Not specify Performance status : Not specify Life expectancy : Not specify Hematopoietic : Not specify Hepatic : Not specify Renal : Not specify Cardiovascular : No New York Heart Association class III IV heart disease At least 14 day since prior myocardial infarction Pulmonary : No severe chronic obstructive pulmonary disease Other : No galactosemia No mental illness handicap PRIOR CONCURRENT THERAPY : Biologic therapy : Not specify Chemotherapy : No prior neoadjuvant chemotherapy Endocrine therapy : Not specify Radiotherapy : Not specify Surgery : See Disease Characteristics At least 1 month since prior core biopsy ( Trucut ) breast cancer</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2005</verification_date>
	<keyword>stage I breast cancer</keyword>
	<keyword>stage II breast cancer</keyword>
	<keyword>stage IIIA breast cancer</keyword>
	<keyword>stage IIIB breast cancer</keyword>
	<keyword>inflammatory breast cancer</keyword>
</DOC>